Wyeth agrees to pay $39 million to settle direct purchasers' claims in US Effexor XR antitrust case
MLex Summary: Wyeth agreed to pay $39 million to resolve direct purchasers’ claims that it unlawfully blocked generic competition for the drug Effexor XR. The settlement is subject to approval by...To view the full article, register now.
Already a subscriber? Click here to view full article